3rd Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for TOLMAR, INC.
Client
Income
$70,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Advocacy around issues affecting the pharmaceutical industry, such as the Medicare Drug Price Negotiation Program under the Inflation Reduction Act.
Foreign entity interest: Tolmar International Ltd, Tolmar Investments Ltd., and Tolmar Holding Ltd. are the ultimate parent companies with an interest pharmaceutical pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY FELDER | — |
| STEPHEN HOLLAND | — |
| LAUREN ALEXANDRA MISH | Intern, Rep. Brian Fitzpatrick (PA-01); Intern, Department of Health and Human Services in the Office of Global Affairs |
| SARA MORSE | — |
| ZACHARY PFISTER | — |
| JOHN REISING New | Scheduler, Operations Director, Member Services Director, Deputy Chief of Staff- Majority Leader Steve Scalise; Operations Director, Rep. Bill Flores; Scheduler, Rep. Austin Scott; Intern, Senator Trent Lott. |
| ADAM STEINMETZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.